Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Benralizumab Atc R03Dx10 For The Time 01 06 2025 31 2027

Deadline: 05 Apr 2027

Germany

Ref. No.: 15669518

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Formoterol Glycopyrronium Budesonide Atc R03Al11 For The Time 01 06 2025 31 20227

Deadline: 05 Apr 2027

Germany

Ref. No.: 15663789

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Open House Original Discount Contracts 2025 15 Tacrolimus Retard Tablets

Deadline: 31 May 2027

Germany

Ref. No.: 15584709

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Open House Biologika Discount Contracts 2025 08 Denosumab

Deadline: 31 May 2027

Germany

Ref. No.: 15548397

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Open House Discount Contracts 2025 05

Deadline: 31 May 2027

Germany

Ref. No.: 15531479

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Formoterol And Fluticason Atc R03Ak11 For The Time 01 06 2025 31 05 2027

Deadline: 05 Apr 2027

Germany

Ref. No.: 15510165

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Alirocumab Atc C10Ax14 For The Time 01 06 2025 31 20227

Deadline: 05 Apr 2027

Germany

Ref. No.: 15508458

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Goserelin Atc L02Ae03 For The Period 01 06 2025 31 20227

Deadline: 05 Apr 2027

Germany

Ref. No.: 15508146

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Erythropoietin Atc B03Xa01 For The Period 01 06 2025 31 05 2027 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2028

Germany

Ref. No.: 15507532

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Tianeptin Atc N06Ax14 For The Time 01 06 2025 31 05 2027 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2028

Germany

Ref. No.: 15505775

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Open House Original Discount Contracts 2025 13 Fluticason Umeclidinium Vilanterol Combination Of Active Ingredients

Deadline: 31 May 2027

Germany

Ref. No.: 15502104

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Latanoprost Exclusively Individual Doses Atc S01Ee01 For The Time 01 06 2025 31 20227

Deadline: 05 Apr 2027

Germany

Ref. No.: 15497186

EMD:Ref Document

Bid Value: Ref Document

538 Days Left

Open House Original Discount Contracts 2025 14 Tiotropium Bromide Olodaterol Combination Of Active Ingredients

Deadline: 31 May 2027

Germany

Ref. No.: 15496790

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Liraglutid Atc A10Bj02 For The Period 01 06 2025 31 05 2027 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2028

Germany

Ref. No.: 15496767

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Ticagrelor Atc B01Ac24 For The Time 01 06 2025 31 05 2027 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2028

Germany

Ref. No.: 15491766

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Showing 49231 to 49245 of 49829 results

‹
1
2
...
3280
3281
3282
3283
3284
3285
3286
...
3321
3322
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!